Top News

• Exclude Liraglutide from Compounding: Novo Nordisk
• Mylan 6-Item Form FDA-483 Posted
• QS, MDR Violations at Rontis Hellas in Greece
• Guide on Drug Batch Uniformity and Integrity
• FDA Alert on Boston Accolade Pacers Early Replacement
• Axsome Plans Alzheimers NDA on Mixed Data
• Global Unique Device ID Database Guidance
• FDA Approves Checkpoints Unloxcyt